logo

For the Inventor, By the Inventor

Chicago, IL, United States of America

Caroline Epstein

USPTO Granted Patents = 11 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal10 out of 63 
 
Tempus Labs, Inc.
 patents
silverMedal1 out of 17 
 
Tempus Ai, Inc.
 patents

Years Active: 2021-2025

Loading Chart...
11 patents (USPTO):Explore Patents
1. 12412665 - Methods for evaluating the effect of the start date for cancer treatment with a cancer medication using propensity scoring (2025-09-09),
2. 11848107 - Predicting likelihood and site of metastasis from patient records (2023-12-19),
3. 11830587 - Method and process for predicting and analyzing patient cohort response, progression, and survival (2023-11-28),
4. 11769572 - Method and process for predicting and analyzing patient cohort response, progression, and survival (2023-09-26),
5. 11715565 - Evaluating effect of event on condition using propensity scoring (2023-08-01),
6. 11699507 - Method and process for predicting and analyzing patient cohort response, progression, and survival (2023-07-11),
7. 11367004 - Real-world evidence of diagnostic testing and treatment patterns in U.S. breast cancer patients with implications for treatment biomarkers from RNA-sequencing data (2022-06-21),
8. 11309090 - Method and process for predicting and analyzing patient cohort response, progression, and survival (2022-04-19),
9. 11244763 - Predicting likelihood and site of metastasis from patient records (2022-02-08),
10. 11145416 - Predicting likelihood and site of metastasis from patient records (2021-10-12),
11. 11037685 - Method and process for predicting and analyzing patient cohort response, progression, and survival (2021-06-15),

Title: The Innovative Contributions of Caroline Epstein

Introduction

Caroline Epstein is a prominent inventor based in Chicago, IL, known for her significant contributions to cancer treatment methodologies. With a total of 11 patents to her name, she has made remarkable strides in the field of oncology, particularly in evaluating treatment strategies and predicting cancer metastasis.

Latest Patents

Among her latest patents, one notable invention is titled "Methods for evaluating the effect of the start date for cancer treatment with a cancer medication using propensity scoring." This patent outlines a method for assessing the optimal start date for cancer treatment by utilizing a model that incorporates various patient features. The process involves selecting subjects based on a propensity value threshold and evaluating treatment start dates with a survival objective.

Another significant patent is "Predicting likelihood and site of metastasis from patient records." This invention provides systems and methods for predicting the metastasis of cancer by analyzing a range of data elements, including gene expression and clinical features. The outcome is a clinical report that indicates the likelihood of cancer spreading, which can be crucial for patient management.

Career Highlights

Caroline has worked with notable companies such as Tempus Labs, Inc. and Tempus AI, Inc., where she has applied her expertise in data-driven cancer research. Her work has been instrumental in advancing personalized medicine and improving patient outcomes through innovative treatment strategies.

Collaborations

Throughout her career, Caroline has collaborated with esteemed colleagues, including Ashraf Hafez and Hailey B Lefkofsky. These partnerships have fostered a collaborative environment that enhances research and development in cancer treatment.

Conclusion

Caroline Epstein's contributions to cancer research and treatment methodologies exemplify the impact of innovation in healthcare. Her patents and collaborative efforts continue to pave the way for advancements in oncology, ultimately benefiting patients and the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…